These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 15114629

  • 1. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW, Lee SH, Kim H, Song JS, Yang SD, Paik SG, Han PL.
    J Neurosci Res; 2004 May 15; 76(4):572-80. PubMed ID: 15114629
    [Abstract] [Full Text] [Related]

  • 2. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC.
    J Alzheimers Dis; 2010 May 15; 20(1):113-26. PubMed ID: 20164597
    [Abstract] [Full Text] [Related]

  • 3. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.
    Lee KW, Im JY, Song JS, Lee SH, Lee HJ, Ha HY, Koh JY, Gwag BJ, Yang SD, Paik SG, Han PL.
    Neurobiol Dis; 2006 Apr 15; 22(1):10-24. PubMed ID: 16289866
    [Abstract] [Full Text] [Related]

  • 4. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.
    Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756
    [Abstract] [Full Text] [Related]

  • 5. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J, Tomita T, Iwatsubo T, Kato S, Aiso S, Nishimoto I, Kouyama K.
    Eur J Neurosci; 2004 May 26; 19(10):2826-38. PubMed ID: 15147316
    [Abstract] [Full Text] [Related]

  • 6. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease.
    Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, Waring JF, Decker MW, Rueter LE, Browman KE.
    Brain Res; 2010 Jan 22; 1311():136-47. PubMed ID: 19944081
    [Abstract] [Full Text] [Related]

  • 7. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S.
    Neurobiol Aging; 2008 Feb 22; 29(2):241-52. PubMed ID: 17112635
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw.
    Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH, Seo SJ, Song YS, Song CW, Paik SG, Sheen YY, Kim YK.
    Exp Neurol; 2004 Mar 22; 186(1):20-32. PubMed ID: 14980807
    [Abstract] [Full Text] [Related]

  • 9. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
    Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW.
    Behav Brain Res; 2004 Aug 12; 153(1):107-21. PubMed ID: 15219712
    [Abstract] [Full Text] [Related]

  • 10. Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Abeta-bearing fragment is associated with reduced NMDA receptor density.
    Boon WC, van den Buuse M, Wegener N, Martin S, Chua HK, Bush AI, Masters CL, Adlard PA, Li QX.
    Behav Brain Res; 2010 May 01; 209(1):27-35. PubMed ID: 20085783
    [Abstract] [Full Text] [Related]

  • 11. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF.
    Eur J Neurosci; 2006 Jan 01; 23(1):251-60. PubMed ID: 16420434
    [Abstract] [Full Text] [Related]

  • 12. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 01; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 13. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.
    J Pineal Res; 2009 Aug 01; 47(1):82-96. PubMed ID: 19538338
    [Abstract] [Full Text] [Related]

  • 14. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice.
    Hyde LA, Kazdoba TM, Grilli M, Lozza G, Brusa R, Zhang Q, Wong GT, McCool MF, Zhang L, Parker EM, Higgins GA.
    Behav Brain Res; 2005 May 28; 160(2):344-55. PubMed ID: 15863231
    [Abstract] [Full Text] [Related]

  • 15. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.
    Zhang L, Xing Y, Ye CF, Ai HX, Wei HF, Li L.
    Behav Brain Res; 2006 Oct 16; 173(2):246-54. PubMed ID: 16901557
    [Abstract] [Full Text] [Related]

  • 16. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M, Konietzko U, Krebs DC, Nitsch RM.
    Neurobiol Aging; 2007 Sep 16; 28(9):1297-306. PubMed ID: 16876915
    [Abstract] [Full Text] [Related]

  • 17. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J.
    Neuroscience; 2006 Dec 28; 143(4):911-22. PubMed ID: 17027170
    [Abstract] [Full Text] [Related]

  • 18. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.
    Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF.
    Brain Res; 2004 Jun 25; 1012(1-2):29-41. PubMed ID: 15158158
    [Abstract] [Full Text] [Related]

  • 19. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
    Van Broeck B, Vanhoutte G, Cuijt I, Pereson S, Joris G, Timmermans JP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S.
    Neurosci Lett; 2008 Dec 12; 447(2-3):143-7. PubMed ID: 18840503
    [Abstract] [Full Text] [Related]

  • 20. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice.
    Dodart JC, Mathis C, Saura J, Bales KR, Paul SM, Ungerer A.
    Neurobiol Dis; 2000 Apr 12; 7(2):71-85. PubMed ID: 10783292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.